摘要
Theranostic nanomedicine paradigm, a combination of specific molecular diagnostic tests and specific targeted therapy, involves two topics:therapeutic product efficacies and diagnosis. The first topic concerns identified patients to be treated, whereas the second is to select patients for personalized medicine. Generally, nanotechnology allows developing theranostic strategy
Theranostic nanomedicine paradigm, a combination of specific molecular diagnostic tests and specific targeted therapy, involves two topics： therapeutic product efficacies and diagnosis. The first topic concerns identified patients to be treated, whereas the second is to select patients for personalized medicine. Generally, nano-technology allows developing theranostic strategy with the same nanoparticle. Theranostics represents a new field of medicine and today it is associated with molecular imaging technologies. In reality, theranostic approach has about a history of 75 years since the use, throughout the world, of radioactive iodine for the well-established diagnosis and treatment of thyroid cancer. It is clear that the emergence of new nanotechnologies has opened new opportunities to bring together diagnosis and tailored therapy approaches. Thus, during the past decade.
